This research demonstrates the stability and print fidelity of freeze-dryable inks using chitosan nanofibers and hyaluronic acid, suggesting improved bioprinting solutions.
Freeze-dryable inks offer significant advantages for bioprinting, such as long-term biochemical and biophysical stability with minimal risks of hydrolysis, denaturation, and microbial contamination. In this study, we developed inks that can be stored in a ready-to-use, freeze-dried form by incorporating chitosan nanofibers (ChitoNFs), sodium hyaluronic acid (HA-Na), and phenolated HA (HA-Ph). HA-Na and HA-Ph effectively inhibited ChitoNF aggregation during drying. Upon rehydration, the developed inks exhibited shear-thinning behavior and underwent horseradish peroxidase-catalyzed gelation. The optimization of the ChitoNF, HA-Na, and HA-Ph concentrations enabled precise control of the viscosity, gelation time, and hydrogel stiffness after rehydration. Using 0.8 w/v% HA-Na, 0.2 w/v% HA-Ph, and 1.5 w/v% ChitoNF, we achieved high-fidelity three-dimensional printing of constructs. Furthermore, the incorporation of 0.5 w/v% phenolated gelatin supported the encapsulation of 10 T1/2 fibroblasts, resulting in more than 90 % viability and a 3.1-fold increase in mitochondrial activity over 7 d. Our findings revealed that pre-mixed, freeze-dryable ChitoNF-HA-Na/HA-Ph bioinks offer a practical and innovative solution for bioprinting. By ensuring long-term storability, quantitative retention of print fidelity and cytocompatibility after rehydration, and simplified logistics for clinical translation, they address unmet needs in current bioink technologies.
No takes yet. Share an insight, caveat, or question.
Hirami et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: